In silico evaluation and feasibility of near margin-less head and neck daily adaptive radiotherapy
CONCLUSIONS: The IOE enables feasible daily ART treatments with reduced margins while enhancing target coverage and reducing OAR doses for HNC patients. A phase II trial recently finished accrual and forthcoming analysis will determine if these dosimetric improvements correlate with improved patient-reported outcomes.PMID:38453056 | DOI:10.1016/j.radonc.2024.110178
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Michael Dohopolski Justin Visak Byongsu Choi Boyu Meng David Parsons Xinran Zhong Enobong Inam Vlad Avkshtol Dominic Moon David Sher Mu-Han Lin Source Type: research
More News: Anatomy | Cancer | Cancer & Oncology | Head and Neck Cancer | Laryngeal Cancer | Men | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | PET Scan | Radiation Therapy | Radiology | Statistics | Study